145 related articles for article (PubMed ID: 9161642)
1. Expression of an immunomodulatory protein known as progesterone induced blocking factor (PIBF) does not correlate with first trimester spontaneous abortions in progesterone supplemented women.
Check JH; Ostrzenski A; Klimek R
Am J Reprod Immunol; 1997 Apr; 37(4):330-4. PubMed ID: 9161642
[TBL] [Abstract][Full Text] [Related]
2. The expression of a progesterone-induced immunomodulatory protein in pregnancy lymphocytes.
Szekeres-Bartho J; Faust Z; Varga P
Am J Reprod Immunol; 1995 Dec; 34(6):342-8. PubMed ID: 8607938
[TBL] [Abstract][Full Text] [Related]
3. The immunological pregnancy protective effect of progesterone is manifested via controlling cytokine production.
Szekeres-Bartho J; Faust Z; Varga P; Szereday L; Kelemen K
Am J Reprod Immunol; 1996 Apr; 35(4):348-51. PubMed ID: 8739452
[TBL] [Abstract][Full Text] [Related]
4. Evidence that the expression of progesterone-induced blocking factor by maternal T-lymphocytes is positively correlated with conception.
Check JH; Arwitz M; Gross J; Szekeres-Bartho J; Wu CH
Am J Reprod Immunol; 1997 Jul; 38(1):6-8. PubMed ID: 9266004
[TBL] [Abstract][Full Text] [Related]
5. Progesterone induced blocking factor seen in pregnancy lymphocytes soon after implantation.
Check JH; Szekeres-Bartho J; O'Shaughnessy A
Am J Reprod Immunol; 1996 Mar; 35(3):277-80. PubMed ID: 8962661
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte immunotherapy (LI) increases serum levels of progesterone induced blocking factor (PIBF).
Check JH; Arwitz M; Gross J; Peymer M; Szekeres-Bartho J
Am J Reprod Immunol; 1997 Jan; 37(1):17-20. PubMed ID: 9138449
[TBL] [Abstract][Full Text] [Related]
7. Miscarriage in the first trimester according to the presence or absence of the progesterone-induced blocking factor at three to five weeks from conception in progesterone supplemented women.
Check JH; Levin E; Bollendorf A; Locuniak J
Clin Exp Obstet Gynecol; 2005; 32(1):13-4. PubMed ID: 15864927
[TBL] [Abstract][Full Text] [Related]
8. Cytokine production by lymphocytes in pregnancy.
Szereday L; Varga P; Szekeres-Bartho J
Am J Reprod Immunol; 1997 Dec; 38(6):418-22. PubMed ID: 9412725
[TBL] [Abstract][Full Text] [Related]
9. Expression of kisspeptin/GPR54 and PIBF/PR in the first trimester trophoblast and decidua of women with recurrent spontaneous abortion.
Wu S; Zhang H; Tian J; Liu L; Dong Y; Mao T
Pathol Res Pract; 2014 Jan; 210(1):47-54. PubMed ID: 24225150
[TBL] [Abstract][Full Text] [Related]
10. Progesterone-induced blocking factor (PIBF) influences the expression of membrane progesterone receptors (mPRs) on peripheral CD4
Rafiee M; Rezaei A; Alipour R; Sereshki N; Motamedi N; Naseri M
Hormones (Athens); 2021 Sep; 20(3):507-514. PubMed ID: 33914290
[TBL] [Abstract][Full Text] [Related]
11. Correlations of the expression of γδ T cells and their co-stimulatory molecules TIGIT, PD-1, ICOS and BTLA with PR and PIBF in the peripheral blood and decidual tissues of women with unexplained recurrent spontaneous abortion.
Liang Q; Tong L; Xiang L; Shen S; Pan C; Liu C; Zhang H
Clin Exp Immunol; 2021 Jan; 203(1):55-65. PubMed ID: 33017473
[TBL] [Abstract][Full Text] [Related]
12. ELISA test for the detection of an immunological blocking factor in human pregnancy serum.
Szekeres-Bartho J; Varga P; Pejtsik B
J Reprod Immunol; 1989 Sep; 16(1):19-29. PubMed ID: 2600930
[TBL] [Abstract][Full Text] [Related]
13. Molecular cloning and immunologic characterization of a novel cDNA coding for progesterone-induced blocking factor.
Polgar B; Kispal G; Lachmann M; Paar C; Nagy E; Csere P; Miko E; Szereday L; Varga P; Szekeres-Bartho J
J Immunol; 2003 Dec; 171(11):5956-63. PubMed ID: 14634107
[TBL] [Abstract][Full Text] [Related]
14. The antiabortive effect of progesterone-induced blocking factor in mice is manifested by modulating NK activity.
Szekeres-Bartho J; Par G; Dombay Gy; Smart YC; Volgyi Z
Cell Immunol; 1997 May; 177(2):194-9. PubMed ID: 9178647
[TBL] [Abstract][Full Text] [Related]
15. A corpus luteum is not a prerequisite for the expression of progesterone induced blocking factor by T-lymphocytes a week after implantation.
Check JH; Szekeres-Bartho J; Nazari P; Katz Y; Check ML
J Assist Reprod Genet; 2001 Nov; 18(11):603-7. PubMed ID: 11804429
[TBL] [Abstract][Full Text] [Related]
16. Urinary progesterone-induced blocking factor concentration is related to pregnancy outcome.
Polgár B; Nagy E; Mikó E; Varga P; Szekeres-Barthó J
Biol Reprod; 2004 Nov; 71(5):1699-705. PubMed ID: 15269099
[TBL] [Abstract][Full Text] [Related]
17. Progesterone directly and indirectly affects perforin expression in cytolytic cells.
Laskarin G; Strbo N; Sotosek V; Rukavina D; Faust Z; Szekeres-Bartho J; Podack ER
Am J Reprod Immunol; 1999 Nov; 42(5):312-20. PubMed ID: 10584987
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of serum progesterone and progesterone-induced blocking factor (PIBF) levels across trimesters in healthy pregnant women.
Lim MK; Ku CW; Tan TC; Lee YHJ; Allen JC; Tan NS
Sci Rep; 2020 Mar; 10(1):3840. PubMed ID: 32123187
[TBL] [Abstract][Full Text] [Related]
19. Progesterone-induced blocking factor inhibits degranulation of natural killer cells.
Faust Z; Laskarin G; Rukavina D; Szekeres-Bartho J
Am J Reprod Immunol; 1999 Aug; 42(2):71-5. PubMed ID: 10476687
[TBL] [Abstract][Full Text] [Related]
20. Changes in progesterone-induced-blocking-factor expression rates following mifepristone administration in termination of pregnancy at 5 to 8 weeks.
Salomon LJ; Rozenberg P; Szekeres-Bartho J; Malagrida L; Giudicelli Y; Ville Y
J Matern Fetal Neonatal Med; 2005 May; 17(5):353-6. PubMed ID: 16147850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
